Find Research Output

Search concepts
Selected Filters
2019

Absolute Quantification of All Identified Plasma Proteins from SWATH Data for Biomarker Discovery

Rice, S. J., Liu, X., Zhang, J. & Belani, C., Feb 1 2019, In : Proteomics. 19, 3, 1800135.

Research output: Contribution to journalArticle

Biomarkers
Blood Proteins
Proteins
Plasma (human)
Monitoring

Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling

Rice, S. J., Liu, X., Zhang, J., Jia, B., Zheng, H. & Belani, C., May 1 2019, In : Lung Cancer. 131, p. 58-61 4 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Interleukin-6
T-Lymphocytes
Population
STAT1 Transcription Factor

A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction

Takebe, N., Beumer, J. H., Kummar, S., Kiesel, B. F., Dowlati, A., O'Sullivan Coyne, G., Piekarz, R., Rubinstein, L., Fogli, L. K., Vaishampayan, U., Goel, S., O'Bryant, C. L., El-Rayes, B. F., Chung, V., Lenz, H. J., Kim, R., Belani, C. P., Tuscano, J. M., Schelman, W., Moore, N. & 2 others, Doroshow, J. H. & Chen, A. P., Nov 1 2019, In : British Journal of Clinical Pharmacology. 85, 11, p. 2499-2511 13 p.

Research output: Contribution to journalArticle

Open Access
Liver Diseases
Pharmacokinetics
Neoplasms
Maximum Tolerated Dose
Liver
1 Citation (Scopus)
Open Access
Phosphorylation
lung neoplasms
Non-Small Cell Lung Carcinoma
Lung Neoplasms
phosphorylation
4 Citations (Scopus)

Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer

Videtic, G. M., Paulus, R., Singh, A. K., Chang, J. Y., Parker, W., Olivier, K. R., Timmerman, R. D., Komaki, R. R., Urbanic, J. J., Stephans, K. L., Yom, S. S., Robinson, C. G., Belani, C. P., Iyengar, P., Ajlouni, M. I., Gopaul, D. D., Gomez Suescun, J. B., McGarry, R. C., Choy, H. & Bradley, J. D., Apr 1 2019, In : International Journal of Radiation Oncology Biology Physics. 103, 5, p. 1077-1084 8 p.

Research output: Contribution to journalArticle

schedules
Non-Small Cell Lung Carcinoma
lungs
radiation therapy
Appointments and Schedules
1 Citation (Scopus)

Membrane trafficking and exocytosis are upregulated in port wine stain blood vessels

Yin, R., Rice, S. J., Wang, J., Gao, L., Tsai, J., Anvari, R. T., Zhou, F., Liu, X., Wang, G., Tang, Y., Jr, M. C. M., Belani, C. P., Chen, D. B., Nelson, J. S. & Tan, W., May 2019, In : Histology and histopathology. 34, 5, p. 479-490 12 p.

Research output: Contribution to journalArticle

Port-Wine Stain
Exocytosis
Blood Vessels
Membranes
Transmission Electron Microscopy

Pemetrexed, bevacizumab, or the combination as maintenance therapy for advanced nonsquamous non–small-cell lung cancer: ECOG-ACRIN 5508

Ramalingam, S. S., Dahlberg, S. E., Belani, C. P., Saltzman, J. N., Pennell, N. A., Nambudiri, G. S., McCann, J. C., Winegarden, J. D., Kassem, M. A., Mohamed, M. K., Rothman, J. M., Lyss, A. P., Horn, L., Stinchcombe, T. E. & Schiller, J. H., Sep 10 2019, In : Journal of Clinical Oncology. 37, 26, p. 2360-2367 8 p.

Research output: Contribution to journalArticle

Pemetrexed
Non-Small Cell Lung Carcinoma
Therapeutics
Survival
Bevacizumab

Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies

Appleman, L. J., Beumer, J. H., Jiang, Y., Lin, Y., Ding, F., Puhalla, S., Swartz, L., Owonikoko, T. K., Donald Harvey, R., Stoller, R., Petro, D. P., Tawbi, H. A., Argiris, A., Strychor, S., Pouquet, M., Kiesel, B., Chen, A. P., Gandara, D., Belani, C. P., Chu, E. & 1 others, Ramalingam, S. S., Dec 1 2019, In : Cancer Chemotherapy and Pharmacology. 84, 6, p. 1289-1301 13 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Pharmacokinetics
Neoplasms
Area Under Curve
3 Citations (Scopus)

Phase II trial of cabozantinib plus erlotinib in patients with advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer with progressive disease on epidermal growth factor receptor tyrosine kinase inhibitor therapy: A California cancer consortium phase II trial (NCI 9303)

Reckamp, K. L., Frankel, P. H., Ruel, N., Mack, P. C., Gitlitz, B. J., Li, T., Koczywas, M., Gadgeel, S. M., Cristea, M. C., Belani, C. P., Newman, E. M., Gandara, D. R. & Lara, P. N., Jan 1 2019, In : Frontiers in Oncology. 9, MAR, 132.

Research output: Contribution to journalArticle

Open Access
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Neoplasms
Mutation
49 Citations (Scopus)

Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer

CASSINI Investigators, Jan 1 2019, In : New England Journal of Medicine. 380, 8, p. 720-728 9 p.

Research output: Contribution to journalArticle

Venous Thromboembolism
Neoplasms
Venous Thrombosis
Placebos
Confidence Intervals

Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database

Tian, S., Zhang, X., Jiang, R., Pillai, R. N., Owonikoko, T. K., Steuer, C. E., Saba, N. F., Pakkala, S., Patel, P. R., Belani, C. P., Khuri, F. R., Curran, W. J., Ramalingam, S. S., Behera, M. & Higgins, K. A., Nov 2019, In : Clinical Lung Cancer. 20, 6, p. 484-493.e6

Research output: Contribution to journalArticle

Propensity Score
Small Cell Lung Carcinoma
Radiotherapy
Thorax
Databases
2018
3 Citations (Scopus)

A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors

Liu, S. V., Groshen, S. G., Kelly, K., Reckamp, K. L., Belani, C., Synold, T. W., Goldkorn, A., Gitlitz, B. J., Cristea, M. C., Gong, I. Y., Semrad, T. J., Xu, Y., Xu, T., Koczywas, M., Gandara, D. R. & Newman, E. M., Oct 1 2018, In : Cancer Chemotherapy and Pharmacology. 82, 4, p. 723-732 10 p.

Research output: Contribution to journalArticle

Topotecan
Tumors
Circulating Neoplastic Cells
Neoplasms
Phosphorylation
72 Citations (Scopus)

Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature

Pillai, R. N., Behera, M., Owonikoko, T. K., Kamphorst, A. O., Pakkala, S., Belani, C. P., Khuri, F. R., Ahmed, R. & Ramalingam, S. S., Jan 15 2018, In : Cancer. 124, 2, p. 271-277 7 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Ligands
Confidence Intervals
Programmed Cell Death 1 Receptor
Databases

Dynamic change of fatigue of pemetrexed maintenance treatment in the JMEN trial

Zhang, L., Belani, C., Zhang, P. H., Wang, X., Yang, L., Orlando, M. & Wu, Y. L., Jan 1 2018, In : Lung Cancer. 115, p. 121-126 6 p.

Research output: Contribution to journalArticle

Pemetrexed
Fatigue
Placebos
Therapeutics
Non-Small Cell Lung Carcinoma
2 Citations (Scopus)

Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers

Joshi, M., Millis, S. Z., Arguello, D., Holder, S. L., Lamm, D., Reddy, S., Belani, C., Drabick, J. J. & Vogelzang, N. J., Jan 2018, In : European Urology Focus. 4, 1, p. 94-97 4 p.

Research output: Contribution to journalArticle

Urinary Bladder Neoplasms
Smoking
History
Mutation
In Situ Hybridization
5 Citations (Scopus)

Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease

Varlotto, J. M., Voland, R., McKie, K., Flickinger, J. C., DeCamp, M. M., Maddox, D., Rava, P., Fitzgerald, T. J., Graeber, G., Rassaei, N., Oliveira, P., Ali, S., Belani, C., Glanzman, J., Wakelee, H. A., Patel, M., Baima, J., Zhang, J. & Walsh, W., Apr 2018, In : Cancer medicine. 7, 4, p. 1211-1220 10 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Economics
Lung
Survival
Insurance
2017
9 Citations (Scopus)

A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer

Belani, C. P., Chakraborty, B. C., Modi, R. I. & Khamar, B., Jan 1 2017, In : Annals of Oncology. 28, 2, p. 298-304 7 p.

Research output: Contribution to journalArticle

Desmocollins
Non-Small Cell Lung Carcinoma
Survival
Drug Therapy
Confidence Intervals
25 Citations (Scopus)

Comparison of concurrent use of thoracic radiation with either carboplatin-paclitaxel or cisplatin-etoposide for patients with stage III non–small-cell lung cancer: A systematic review

Steuer, C. E., Behera, M., Ernani, V., Higgins, K. A., Saba, N. F., Shin, D. M., Pakkala, S., Pillai, R. N., Owonikoko, T. K., Curran, W. J., Belani, C., Khuri, F. R. & Ramalingam, S. S., Aug 1 2017, In : JAMA Oncology. 3, 8, p. 1120-1129 10 p.

Research output: Contribution to journalReview article

Carboplatin
Etoposide
Non-Small Cell Lung Carcinoma
Paclitaxel
Thorax
41 Citations (Scopus)

National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer

Higgins, K. A., O'Connell, K., Liu, Y., Gillespie, T. W., McDonald, M. W., Pillai, R. N., Patel, K. R., Patel, P. R., Robinson, C. G., Simone, C. B., Owonikoko, T. K., Belani, C. P., Khuri, F. R., Curran, W. J., Ramalingam, S. S. & Behera, M., Jan 1 2017, In : International Journal of Radiation Oncology Biology Physics. 97, 1, p. 128-137 10 p.

Research output: Contribution to journalArticle

Proton Therapy
Photons
Non-Small Cell Lung Carcinoma
lungs
Protons
3 Citations (Scopus)

Phase I study of veliparib in combination with gemcitabine

Stoller, R., Schmitz, J. C., Ding, F., Puhalla, S., Belani, C. P., Appleman, L., Lin, Y., Jiang, Y., Almokadem, S., Petro, D., Holleran, J., Kiesel, B. F., Ken Czambel, R., Carneiro, B. A., Kontopodis, E., Hershberger, P. A., Rachid, M., Chen, A., Chu, E. & Beumer, J. H., Sep 1 2017, In : Cancer Chemotherapy and Pharmacology. 80, 3, p. 631-643 13 p.

Research output: Contribution to journalArticle

gemcitabine
Appointments and Schedules
Pharmacokinetics
Pharmacodynamics
Toxicity
2 Citations (Scopus)

Posttraumatic Symptoms, Quality of Life, and Survival among Lung Cancer Patients

Liegey Dougall, A., Swanson, J., Kyutoku, Y., Belani, C. P. & Baum, A., Sep 2017, In : Journal of Applied Biobehavioral Research. 22, 3, e12065.

Research output: Contribution to journalArticle

Lung Neoplasms
quality of life
cancer
Quality of Life
Survival
54 Citations (Scopus)

Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes

Wan, Y., Cheng, G., Liu, X., Hao, S. J., Nisic, M., Zhu, C. D., Xia, Y. Q., Li, W. Q., Wang, Z. G., Zhang, W. L., Rice, S. J., Sebastian, A., Albert, I., Belani, C. P. & Zheng, S. Y., Apr 10 2017, In : Nature Biomedical Engineering. 1, 4, 0058.

Research output: Contribution to journalArticle

Nanoprobes
Nucleic acids
Nucleic Acids
Lipids
Proteins
21 Citations (Scopus)

Rivaroxaban for preventing venous thromboembolism in high-risk ambulatory patients with cancer: Rationale and design of the CASSINI trial

Khorana, A. A., Vadhan-Raj, S., Kuderer, N. M., Wun, T., Liebman, H., Soff, G., Belani, C., O'Reilly, E. M., McBane, R., Eikelboom, J., Damaraju, C. V., Beyers, K., Dietrich, F., Kakkar, A. K., Riess, H., Peixoto, R. D. A. & Lyman, G. H., Jan 1 2017, In : Thrombosis and Haemostasis. 117, 11, p. 2135-2145 11 p.

Research output: Contribution to journalArticle

Venous Thromboembolism
Neoplasms
Placebos
Ultrasonography
Upper Extremity Deep Vein Thrombosis
2016

A patient with complex multiple genomic alk alterations

Liu, X., Rice, S. J., Jamis-Dow, C. A., Abendroth, C., Ali, S., Almokadem, S. & Belani, C. P., Apr 2016, In : Thorax. 71, 4, p. 383-385 3 p.

Research output: Contribution to journalReview article

Serine Endopeptidases
Histone-Lysine N-Methyltransferase
Pyrazoles
MAP Kinase Kinase 4
Pyridines
1 Citation (Scopus)

A week in the life of lung cancer survivors: Daily reports of stress, worry, mood, and symptoms

Aronson, K. R., Wagstaff, D. A., Farace, E., Muscat, J., Belani, C., Almokadem, S. & Fossum, T., Oct 1 2016, In : Journal of Health Psychology. 21, 10, p. 2269-2282 14 p.

Research output: Contribution to journalArticle

Survivors
Lung Neoplasms
Interviews
Multilevel Analysis
Survival Rate

Clinical advances in immuno-oncology-progress towards selective cure

Liu, X. & Belani, C., Aug 1 2016, In : Current Molecular Pharmacology. 9, 3, 1 p.

Research output: Contribution to journalEditorial

Clinical approaches to immunotherapy in non-small cell lung cancer: Current and future perspectives

Rice, S. J., Miller, B., Wagman, M., Jamorabo, D. S., Liu, X. & Belani, C. P., Aug 1 2016, In : Current Molecular Pharmacology. 9, 3, p. 183-195 13 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Immunotherapy
Lung Neoplasms
Cancer Vaccines
Therapeutics
7 Citations (Scopus)

Difference in restricted mean survival time for cost-effectiveness analysis using individual patient data meta-analysis: Evidence from a case study

MAR-LC Collaborative Group, Mar 2016, In : PloS one. 11, 3, e0150032.

Research output: Contribution to journalArticle

cost effectiveness
Cost effectiveness
Metadata
meta-analysis
Cost-Benefit Analysis
7 Citations (Scopus)

Docetaxel Combined with Bavituximab in Previously Treated, Advanced Nonsquamous Non-Small-Cell Lung Cancer

Gerber, D. E., Spigel, D. R., Giorgadze, D., Shtivelband, M., Ponomarova, O. V., Shan, J. S., Menander, K. B. & Belani, C. P., May 1 2016, In : Clinical Lung Cancer. 17, 3, p. 169-176 8 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Confidence Intervals
Placebos
bavituximab
23 Citations (Scopus)

Expression of PD-1 on CD4+ T cells in peripheral blood associates with poor clinical outcome in non-small cell lung cancer

Zheng, H., Liu, X., Zhang, J., Rice, S. J., Wagman, M., Kong, Y., Zhu, L., Zhu, J., Joshi, M. & Belani, C. P., Jan 1 2016, In : Oncotarget. 7, 35, p. 56233-56240 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cell Death
T-Lymphocytes
Neoplasms
Blocking Antibodies
7 Citations (Scopus)

Pulmonary Rehabilitation in Lung Cancer

Wang, H., Liu, X., Rice, S. J. & Belani, C., Oct 1 2016, In : PM and R. 8, 10, p. 990-996 7 p.

Research output: Contribution to journalReview article

Lung Neoplasms
Rehabilitation
Lung
Lung Diseases
Survivors
1 Citation (Scopus)

Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC

Ardizzoni, A., Tiseo, M., Boni, L., Di Maio, M., Buffoni, L., Belvedere, O., Grossi, F., D'Alessandro, V., de Marinis, F., Barbera, S., Caroti, C., Favaretto, A., Cortinovis, D., Morrica, B., Tixi, L., Ceschia, T., Parisi, S., Ricardi, U., Grimaldi, A., Loreggian, L. & 6 others, Navarria, P., Huber, R. M., Belani, C., Bruswig, P. F., Scagliotti, G. V. & Scolaro, T., Oct 1 2016, In : Lung Cancer. 100, p. 30-37 8 p.

Research output: Contribution to journalArticle

Induction Chemotherapy
Meta-Analysis
Radiotherapy
Thorax
Drug Therapy
22 Citations (Scopus)

Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005

Behera, M., Ragin, C., Kim, S., Pillai, R. N., Chen, Z., Steuer, C. E., Saba, N. F., Belani, C. P., Khuri, F. R., Ramalingam, S. S. & Owonikoko, T. K., Jan 1 2016, In : Cancer. 122, 1, p. 50-60 11 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Drug Therapy
Survival
Medicare
Confidence Intervals
30 Citations (Scopus)

Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN cancer research group (E1508)

Belani, C. P., Dahlberg, S. E., Rudin, C. M., Fleisher, M., Chen, H. X., Takebe, N., Velasco, M. R., Tester, W. J., Sturtz, K., Hann, C. L., Shanks, J. C., Monga, M., Ramalingam, S. S. & Schiller, J. H., Jan 1 2016, In : Cancer. 122, 15, p. 2371-2378 8 p.

Research output: Contribution to journalArticle

HhAntag691
Small Cell Lung Carcinoma
Circulating Neoplastic Cells
Arm
Drug Therapy
2015
26 Citations (Scopus)

Afatinib for the treatment of metastatic non-small cell lung cancer

Joshi, M., Rizvi, S. M. & Belani, C. P., Jan 1 2015, In : Cancer Management and Research. 7, p. 75-82 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Exons
Epidermal Growth Factor Receptor
Mutation
Therapeutics
35 Citations (Scopus)

A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511)

Owonikoko, T. K., Dahlberg, S. E., Khan, S. A., Gerber, D. E., Dowell, J., Moss, R. A., Belani, C. P., Hann, C. L., Aggarwal, C. & Ramalingam, S. S., Jul 1 2015, In : Lung Cancer. 89, 1, p. 66-70 5 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Cisplatin
Safety
Research
2 Citations (Scopus)

A phase I study of DMS612, a novel bifunctional alkylating agent

Appleman, L. J., Balasubramaniam, S., Parise, R. A., Bryla, C., Redon, C. E., Nakamura, A. J., Bonner, W. M., Wright, J. J., Piekarz, R., Kohler, D. R., Jiang, Y., Belani, C. P., Eiseman, J., Chu, E., Beumer, J. H. & Bates, S. E., Feb 15 2015, In : Clinical Cancer Research. 21, 4, p. 721-729 9 p.

Research output: Contribution to journalArticle

NSC281612
Alkylating Agents
Maximum Tolerated Dose
Renal Cell Carcinoma
Fluorescent Antibody Technique
13 Citations (Scopus)

Bevacizumab in combination with taxane versus non-taxane containing regimens for advanced/metastatic nonsquamous non-small-cell lung cancer a systematic review

Behera, M., Pillai, R. N., Owonikoko, T. K., Kim, S., Steuer, C., Chen, Z., Saba, N. F., Belani, C. P., Khuri, F. R. & Ramalingam, S. S., Aug 1 2015, In : Journal of Thoracic Oncology. 10, 8, p. 1142-1147 6 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Disease-Free Survival
Angiogenesis Inhibitors
Survival
Cytotoxins
2 Citations (Scopus)

Complex chronic conditions in Rhode Island's pediatric populace: Implications for palliative and hospice services, 2000-2012

Jamorabo, D. S., Belani, C. P. & Martin, E. W., Apr 1 2015, In : Journal of palliative medicine. 18, 4, p. 350-357 8 p.

Research output: Contribution to journalReview article

Hospices
Pediatrics
Hospice Care
Palliative Care
Comorbidity
11 Citations (Scopus)

Niclosamide, an anti-helminthic molecule, downregulates the retroviral oncoprotein Tax and pro-survival Bcl-2 proteins in HTLV-1-transformed T lymphocytes

Xiang, D., Yuan, Y., Chen, L., Liu, X., Belani, C. & Cheng, H., Jul 20 2015, In : Biochemical and Biophysical Research Communications. 464, 1, p. 221-228 8 p.

Research output: Contribution to journalArticle

Niclosamide
Deltaretrovirus
T-cells
Oncogene Proteins
Taxation
19 Citations (Scopus)

Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival

Varlotto, J. M., Yao, A. N., Decamp, M. M., Ramakrishna, S., Recht, A., Flickinger, J., Andrei, A., Reed, M. F., Toth, J. W., Fizgerald, T. J., Higgins, K., Zheng, X., Shelkey, J., Medford-Davis, L. N., Belani, C. & Kelsey, C. R., Mar 15 2015, In : International Journal of Radiation Oncology Biology Physics. 91, 4, p. 765-773 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
lungs
cancer
Recurrence
Survival
15 Citations (Scopus)

Proteomic profiling of human plasma identifies apolipoprotein E as being associated with smoking and a marker for squamous metaplasia of the lung

Rice, S. J., Liu, X., Miller, B., Joshi, M., Zhu, J., Caruso, C., Gilbert, C., Toth, J., Reed, M., Rassaei, N., Das, A., Barochia, A., El-Bayoumy, K. & Belani, C. P., Sep 1 2015, In : Proteomics. 15, 18, p. 3267-3277 11 p.

Research output: Contribution to journalArticle

Plasma (human)
Metaplasia
Apolipoproteins E
Proteomics
Biomarkers
1 Citation (Scopus)
Biomarkers
Adenoma
Proteomics
Hyperplasia
Lung
30 Citations (Scopus)

Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer

Ramalingam, S. S., Shtivelband, M., Soo, R. A., Barrios, C. H., Makhson, A., Segalla, J. G. M., Pittman, K. B., Kolman, P., Pereira, J. R., Srkalovic, G., Belani, C. P., Axelrod, R., Owonikoko, T. K., Qin, Q., Qian, J., McKeegan, E. M., Devanarayan, V., McKee, M. D., Ricker, J. L., Carlson, D. M. & 1 others, Gorbunova, V. A., Feb 10 2015, In : Journal of Clinical Oncology. 33, 5, p. 433-442 10 p.

Research output: Contribution to journalArticle

N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N1-(2-fluoro-5-methylphenyl)urea
Carboplatin
Paclitaxel
Non-Small Cell Lung Carcinoma
Placebos
7 Citations (Scopus)

Tid1, the mammalian homologue of Drosophila tumor suppressor Tid56, mediates macroautophagy by interacting with beclin1-containing autophagy protein complex

Niu, G., Zhang, H., Liu, D., Chen, L., Belani, C., Wang, H. G. & Cheng, H., Jul 17 2015, In : Journal of Biological Chemistry. 290, 29, p. 18102-18110 9 p.

Research output: Contribution to journalArticle

Autophagy
Drosophila
Tumors
Nutrients
Neoplasms
35 Citations (Scopus)

Trametinib with or without Vemurafenib in braf mutated non-small cell lung cancer

Joshi, M., Rice, S. J., Liu, X., Miller, B. & Belani, C. P., Feb 23 2015, In : PloS one. 10, 2, 0118210.

Research output: Contribution to journalArticle

lung neoplasms
Non-Small Cell Lung Carcinoma
Cells
Mitogen-Activated Protein Kinase Kinases
Up-Regulation
2014

Clinical significance of viable-enriched circulating tumor cells with a flexible micro spring array

Harouaka, R., Liu, X., Khan, W., Khan, T., Rice, S., Belani, C. & Zheng, S., Jan 1 2014, 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2014. Chemical and Biological Microsystems Society, p. 579-581 3 p. (18th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2014).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Tumors
Cells
Blood
Biomarkers
Antigens
64 Citations (Scopus)

Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells

Harouaka, R. A., Zhou, M. D., Yeh, Y. T., Khan, W. J., Das, A., Liu, X., Christ, C. C., Dicker, D. T., Baney, T. S., Kaifi, J. T., Belani, C. P., Truica, C. I., El-Deiry, W. S., Allerton, J. P. & Zheng, S. Y., Feb 1 2014, In : Clinical Chemistry. 60, 2, p. 323-333 11 p.

Research output: Contribution to journalArticle

Circulating Neoplastic Cells
Tumors
Cells
Throughput
Equipment and Supplies
50 Citations (Scopus)

Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer

Ji, C., Zhang, L., Cheng, Y., Patel, R., Wu, H., Zhang, Y., Wang, M., Ji, S., Belani, C. P., Yang, J. M. & Ren, X., May 2014, In : Cancer Biology and Therapy. 15, 5, p. 570-577 8 p.

Research output: Contribution to journalArticle

Autophagy
Lung Neoplasms
Drug Resistance
Chloroquine
Non-Small Cell Lung Carcinoma
7 Citations (Scopus)

Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer

Jiang, Y., Mackley, H., Kimchi, E. T., Zhu, J., Gusani, N. J., Kaifi, J., Staveley-O'Carroll, K. F. & Belani, C., Jan 1 2014, In : Cancer Chemotherapy and Pharmacology. 74, 1, p. 205-210 6 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Radiation
Radiotherapy
Fluorouracil
Survival